XNCR
Xencor, Inc. · Healthcare · Biotechnology
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -5.9% · netto nieuwe posities -6.2% · formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q3 2025
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 28.41K | $397,905 | n/a | −1 |
| Q2 2026 | 80 | +2 | 51.89M | $834.92M | +6 | −4 |
| Q1 2026 | 81 | -4 | 48.47M | $584.53M | +2 | −7 |
| Q4 2025 | 85 | +1 | 50.89M | $779.05M | +3 | −1 |
| Q3 2025 | 16 | 0 | 41.61M | $488.08M | +1 | −2 |
| Q2 2025 | 14 | -1 | 41.55M | $326.56M | n/a | −1 |
| Q1 2025 | 12 | +2 | 20.83M | $221.62M | +3 | −1 |
| Q4 2024 | 10 | -2 | 20.65M | $474.47M | +1 | −3 |
| Q3 2024 | 11 | -2 | 20.50M | $412.29M | n/a | −2 |
| Q2 2024 | 13 | n/a | 17.96M | $339.91M | n/a | n/a |
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 11.81M | -0.4% | $138.50M | 0.0% | ▼ Trim | 2 | SEC ↗ ×13 |
| 2 | PRIMECAP Management ✦ | 10.68M | +1.4% | $125.22M | 0.1% | ▲ Add | 6 | SEC ↗ |
| 3 | The Vanguard Group ✦ (passief) | 7.10M | -17.6% | $83.33M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 4 | State Street Global Advisors ✦ (passief) | 3.67M | -3.8% | $43.09M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passief) | 1.73M | +1.5% | $20.28M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | T. Rowe Price ✦ | 1.69M | -55.0% | $19.86M | 0.0% | ▼ Trim | 6 | SEC ↗ ×2 |
| 7 | Goldman Sachs Group ✦ | 1.02M | n/a | $11.93M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 8 | Morgan Stanley ✦ | 900.84K | n/a | $10.57M | 0.0% | n/c | 1 | SEC ↗ ×8 |
| 9 | JPMorgan Chase ✦ | 803.00K | n/a | $9.42M | 0.0% | n/c | 1 | SEC ↗ ×12 |
| 10 | Millennium Management ✦ | 702.57K | +102.5% | $8.24M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Two Sigma Investments ✦ | 629.38K | +43.1% | $7.38M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 481.17K | +118.5% | $5.64M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 13 | Renaissance Technologies ✦ | 190.39K | +242.4% | $2.23M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | AQR Capital Management ✦ | 86.82K | -9.8% | $1.02M | 0.0% | ▼ Trim | 3 | SEC ↗ ×4 |
| 15 | Fidelity (FMR) ✦ | 73.93K | +8.2% | $867,200 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 16 | Marshall Wace ✦ | 41.72K | Nieuw | $489,329 | 0.0% | New | 1 | SEC ↗ |
"Hun weging" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die manager: de overtuigingsmaatstaf. ✦ = gecureerde manager.
Nieuwe kopers
| Marshall Wace | $489,329 | 0.0% |
Verlaten
| Norges Bank | $234,739 | was 0.0% |
| Point72 Asset Management | $12,247 | was 0.0% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 202 houders, 84.29M aandelen, $988.19M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Wat de gevolgde houders van dit effect het vaakst nog meer bezitten: aantallen gedeeld eigendom, geen fundamentele relaties.